| Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy NM Archin, AL Liberty, AD Kashuba, SK Choudhary, JD Kuruc, ... Nature 487 (7408), 482-485, 2012 | 1271 | 2012 |
| Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection rgp120 HIV Vaccine Study Group The Journal of infectious diseases 191 (5), 654-665, 2005 | 1258 | 2005 |
| Toward causal inference with interference MG Hudgens, ME Halloran Journal of the American Statistical Association 103 (482), 832-842, 2008 | 806 | 2008 |
| Obesity is associated with impaired immune response to influenza vaccination in humans PA Sheridan, HA Paich, J Handy, EA Karlsson, MG Hudgens, ... International Journal of Obesity, 2011 | 614 | 2011 |
| Maternal or infant antiretroviral drugs to reduce HIV-1 transmission CS Chasela, MG Hudgens, DJ Jamieson, D Kayira, MC Hosseinipour, ... New England Journal of Medicine 362 (24), 2271-2281, 2010 | 544 | 2010 |
| Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial PB Gilbert, ML Peterson, D Follmann, MG Hudgens, DP Francis, ... Journal of Infectious Diseases 191 (5), 666, 2005 | 459 | 2005 |
| HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy JB Honeycutt, WO Thayer, CE Baker, RM Ribeiro, SM Lada, Y Cao, ... Nature medicine 23 (5), 638-643, 2017 | 284 | 2017 |
| A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without … ML Cottrell, KH Yang, HMA Prince, C Sykes, N White, S Malone, ... The Journal of infectious diseases 214 (1), 55-64, 2016 | 276 | 2016 |
| Generalizing study results: a potential outcomes perspective CR Lesko, AL Buchanan, D Westreich, JK Edwards, MG Hudgens, ... Epidemiology (Cambridge, Mass.) 28 (4), 553, 2017 | 260 | 2017 |
| Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta‐analysis AF Rositch, J Koshiol, MG Hudgens, H Razzaghi, DM Backes, ... International journal of cancer 133 (6), 1271-1285, 2013 | 251 | 2013 |
| Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa V Leroy, JM Karon, A Alioum, ER Ekpini, N Meda, AE Greenberg, ... Aids 16 (4), 631, 2002 | 250 | 2002 |
| Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus … S Subbarao, RA Otten, A Ramos, C Kim, E Jackson, M Monsour, ... Journal of Infectious Diseases 194 (7), 904-911, 2006 | 249 | 2006 |
| Increased risk of influenza among vaccinated adults who are obese SD Neidich, WD Green, J Rebeles, EA Karlsson, S Schultz-Cherry, ... International journal of obesity 41 (9), 1324-1330, 2017 | 246 | 2017 |
| Immune and genetic correlates of vaccine protection against mucosal infection by SIV in monkeys NL Letvin, SS Rao, DC Montefiori, MS Seaman, Y Sun, SY Lim, WW Yeh, ... Science translational medicine 3 (81), 81ra36-81ra36, 2011 | 207 | 2011 |
| Evaluating candidate principal surrogate endpoints PB Gilbert, MG Hudgens Biometrics 64 (4), 1146-1154, 2008 | 206 | 2008 |
| Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials PB Gilbert, RJ Bosch, MG Hudgens Biometrics 59 (3), 531-541, 2003 | 197 | 2003 |
| Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus HA Paich, PA Sheridan, J Handy, EA Karlsson, S Schultz‐Cherry, ... Obesity 21 (11), 2377-2386, 2013 | 188 | 2013 |
| Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid‐based cytology in primary cervical cancer screening: The FASE study J Monsonego, MG Hudgens, L Zerat, JC Zerat, K Syrjänen, P Halfon, ... International Journal of Cancer 129 (3), 691-701, 2011 | 174 | 2011 |
| Comparison of group testing algorithms for case identification in the presence of test error HY Kim, MG Hudgens, JM Dreyfuss, DJ Westreich, CD Pilcher Biometrics 63 (4), 1152-1163, 2007 | 171 | 2007 |
| Average treatment effects in the presence of unknown interference F Sävje, PM Aronow, MG Hudgens The Annals of Statistics 49 (2), 673-701, 2021 | 151 | 2021 |
Katie R MollanUniversity of North Carolina at Chapel HillVerified email at email.unc.edu
